GLP1R and cardiovascular disorder: In Denmark, metformin-treated patients with a high household income were more likely to initiate second-line treatment with a GLP-1 RA compared to those with low household income, and this finding was consistent in a subgroup analysis irrespective of presence of cardiovascular disease [16].